| 1 |
|
CHEMOKINES - Analysis of the CC chemokine receptor 3 gene reveals a complex 5' exon organization, a functional role for untranslated exon 1, and a broadly active promoter with eosinophil-selective elements/
|
Zimmermann, N
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 2 |
|
CHEMOKINES - Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78b into a most efficient monocyte attractant and CCR1 agonist/
|
Proost, P
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 3 |
|
CHEMOKINES - Down-regulation of neutrophil functions by the ELR+ CXC chemokine platelet basic protein/
|
Ehlert, J E
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 4 |
|
CHEMOKINES - Exaggerated response to endotoxin in mice lacking the Duffy antigen/receptor for chemokines (DARC)/
|
Dawson, T C
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 5 |
|
CHEMOKINES - Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-a and leaves RANTES and MCP-2 intact/
|
Steen, P E Van den
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 6 |
|
CHEMOKINES - Presentation of chemokine SDF-1a by fibronectin mediates directed migration of T cells/
|
Pelletier, A J
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 7 |
|
CHEMOKINES - Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3a/CCL20 in human B cells/
|
Krzysiek, R
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 8 |
|
CHEMOKINES - T-lymphocyte production of macrophage inflammatory protein-1a is critical to the recruitment of CD8+ T cells to the liver, lung, and spleen during graft-versus-host disease/
|
Serody, J S
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 9 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - 2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia/
|
Koshy, M
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 10 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Acute megakaryocytic leukemia: The Eastern Cooperative Oncology Group experience/
|
Tallman, M S
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 11 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation/
|
Thomson, B G
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 12 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Antihirudin antibodies in patients with heparin-induced thrombocytopenia treated with lepirudin: Incidence, effects on aPTT, and clinical relevance/
|
Eichler, P
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 13 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Biochemical markers of bone turnover following high-dose chemotherapy and autografting in multiple myeloma/
|
Clark, R E
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 14 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Bone marrow transplantation versus chemotherapy in the treatment of very high-risk childhood acute lymphoblastic leukemia in first remission: Results from Medical Research Council UKALL X and XI/
|
Wheeler, K A
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 15 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor cell content is a better predictor than nucleated cell quantity/
|
Migliaccio, A R
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 16 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy/
|
Matthews, G V
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 17 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: Report of a prospective, randomized, multicenter trial/
|
Robak, T
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 18 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia/
|
Coustan-Smith, E
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 19 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: Results of a GITMO/EBMT randomized trial/
|
Locatelli, F
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
| 20 |
|
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS - Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: A prospective randomized study/
|
Ruutu, T
|
W.B. Saunders Co., etc.]
|
2000
|
|
|
|
기사
(51)
